somaxon pharmaceuticals
Investor FAQ's
About Us Product Canidates Therapuetic Areas Insomnia Market Investor Releations News Contact Us
Home > Investor Relations > Investor FAQ's
Investor FAQ's
When was Somaxon Pharmaceuticals Inc. founded?
What does Somaxon do?
When was Somaxon's initial public offering (IPO)?
Does Somaxon pay a dividend on its common stock?
Does Somaxon have a direct stock purchase program?
How many shares of common stock does Somaxon have outstanding?
When does Somaxon's fiscal year end?
How many people does Somaxon employ?
Who is Somaxon's stock transfer agent?
How can I get more information about Somaxon?
Where is Somaxon's Headquarters?
What is Somaxon's ticker symbol?
When is Somaxon's next Annual Meeting of Stockholders?
Who can I contact for information about my shares, transfer of my shares, change of address or lost stock certificates?
Who are the members of your senior management team?
Who is on your Board of Directors?
Does Somaxon have any upcoming investor events?
At what stage in development are your drug compounds?
Where can I find information on participating in a clinical trial?
Has Somaxon submitted the NDA for SILENOR™?
Has the NDA been accepted by the FDA?
Do you have another question that hasn't been answered?